| Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle C Yu, Y Chen, GW Cline, D Zhang, H Zong, Y Wang, R Bergeron, JK Kim, ... Journal of Biological Chemistry 277 (52), 50230-50236, 2002 | 1895 | 2002 |
| Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR RR Russell III, R Bergeron, GI Shulman, LH Young American Journal of Physiology-Heart and Circulatory Physiology 277 (2 …, 1999 | 727 | 1999 |
| Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis R Bergeron, JM Ren, KS Cadman, IK Moore, P Perret, M Pypaert, ... American Journal of Physiology-Endocrinology and Metabolism 281 (6), E1340-E1346, 2001 | 708 | 2001 |
| Effect of AMPK activation on muscle glucose metabolism in conscious rats R Bergeron, RR Russell III, LH Young, JM Ren, M Marcucci, A Lee, ... American Journal of Physiology-Endocrinology And Metabolism 276 (5), E938-E944, 1999 | 431 | 1999 |
| Effect of 5-Aminoimidazole-4-Carboxamide-1-β-d-Ribofuranoside Infusion on In Vivo Glucose and Lipid Metabolism in Lean and Obese Zucker Rats R Bergeron, SF Previs, GW Cline, P Perret, RR Russell III, LH Young, ... Diabetes 50 (5), 1076-1082, 2001 | 414 | 2001 |
| Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase–1 G Jiang, Z Li, F Liu, K Ellsworth, Q Dallas-Yang, M Wu, J Ronan, C Esau, ... The Journal of clinical investigation 115 (4), 1030-1038, 2005 | 332 | 2005 |
| Intramuscular Glycogen and Intramyocellular Lipid Utilization during Prolonged Exercise and Recovery in Man: A 13C and 1H Nuclear Magnetic Resonance … M Krssak, KF Petersen, R Bergeron, T Price, D Laurent, DL Rothman, ... The Journal of Clinical Endocrinology & Metabolism 85 (2), 748-754, 2000 | 253 | 2000 |
| Physiological role of AMP-activated protein kinase in the heart: graded activation during exercise DL Coven, X Hu, L Cong, R Bergeron, GI Shulman, DG Hardie, LH Young American Journal of Physiology-Endocrinology and Metabolism 285 (3), E629-E636, 2003 | 215 | 2003 |
| Dipeptidyl peptidase‐4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP‐1 EM Migoya, R Bergeron, JL Miller, RNK Snyder, M Tanen, D Hilliard, ... Clinical Pharmacology & Therapeutics 88 (6), 801-808, 2010 | 201 | 2010 |
| Dipeptidyl peptidase‐4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP‐1 EM Migoya, R Bergeron, JL Miller, RNK Snyder, M Tanen, D Hilliard, ... Clinical Pharmacology & Therapeutics 88 (6), 801-808, 2010 | 201 | 2010 |
| Dipeptidyl peptidase‐4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP‐1 EM Migoya, R Bergeron, JL Miller, RNK Snyder, M Tanen, D Hilliard, ... Clinical Pharmacology & Therapeutics 88 (6), 801-808, 2010 | 201 | 2010 |
| Regulation of net hepatic glycogenolysis and gluconeogenesis during exercise: impact of type 1 diabetes KF Petersen, TB Price, R Bergeron The Journal of Clinical Endocrinology & Metabolism 89 (9), 4656-4664, 2004 | 159 | 2004 |
| Prolonged voluntary wheel‐running stimulates neural precursors in the hippocampus and forebrain of adult CD1 mice MR Bednarczyk, A Aumont, S Décary, R Bergeron, KJL Fernandes Hippocampus 19 (10), 913-927, 2009 | 112 | 2009 |
| Glucose-lowering in a db/db mouse model by dihydropyridine diacid glycogen phosphorylase inhibitors AK Ogawa, CA Willoughby, R Bergeron, KP Ellsworth, WM Geissler, ... Bioorganic & medicinal chemistry letters 13 (20), 3405-3408, 2003 | 104 | 2003 |
| Mechanism by which fatty acids inhibit insulin activation of IRS-1 associated phosphatidylinositol 3-kinase activity in muscle C Yu, Y Chen, H Zong, Y Wang, R Bergeron, JK Kim, GW Cline, ... J Biol Chem 277 (52), 50230-6, 2002 | 77 | 2002 |
| Regulation of myocardial glucose uptake and transport during ischemia and energetic stress LH Young, RR Russell III, R Yin, MJ Caplan, J Ren, R Bergeron, ... The American journal of cardiology 83 (12), 25-30, 1999 | 73 | 1999 |
| Effect of adrenaline on glucose kinetics during exercise in adrenalectomised humans K Howlett, H Galbo, J Lorentsen, R Bergeron, T Zimmerman-Belsing, ... The Journal of Physiology 519 (Pt 3), 911, 1999 | 66 | 1999 |
| Fatty acid oxidation is decreased in the liver of ovariectomized rats A Paquette, NA Chapados, R Bergeron, JM Lavoie Hormone and metabolic research, 511-515, 2009 | 60 | 2009 |
| Voluntary running exercise prevents β-cell failure in susceptible islets of the Zucker diabetic fatty rat V Delghingaro-Augusto, S Décary, ML Peyot, MG Latour, J Lamontagne, ... American Journal of Physiology-Endocrinology and Metabolism 302 (2), E254-E264, 2012 | 58 | 2012 |
| A new class of glycogen phosphorylase inhibitors Z Lu, J Bohn, R Bergeron, Q Deng, KP Ellsworth, WM Geissler, G Harris, ... Bioorganic & medicinal chemistry letters 13 (22), 4125-4128, 2003 | 50 | 2003 |
